See the DrugPatentWatch profile for Eribulin
What is eribulin (eribulin API) used for?
Eribulin (often referred to as “eribulin API” when discussing the active pharmaceutical ingredient) is an anti-cancer medicine used to treat certain breast cancers, including metastatic or locally advanced disease after prior chemotherapy in appropriate patients. [1]
What cancers does eribulin treat?
Eribulin is used in breast cancer settings; the most common labeled use is for metastatic breast cancer that has progressed after prior treatments. [1]
What is “API” and how does it relate to eribulin products?
“API” means active pharmaceutical ingredient. Eribulin API is the drug substance that is formulated into finished pharmaceutical products (such as tablets or injections, depending on the specific marketed form). [2]
How is eribulin given?
Eribulin is administered as an injection in clinical use. [1]
Who makes eribulin API and where is it sourced?
The specific manufacturer and sourcing vary by country and finished-product supplier. If you tell me your country (or whether you mean procurement for manufacturing vs. clinical information), I can narrow down the most relevant sources and regulatory listings.
Safety and patient questions people ask about eribulin
People commonly look for information on chemotherapy side effects (for example, fatigue and low blood counts) and whether eribulin affects pregnancy or fertility. Check the local prescribing information for the most accurate risks for your patient population. [1]
If you mean procurement: what do you typically need for eribulin API?
For drug-substance procurement, buyers usually need documentation such as GMP manufacturing information, specifications, and regulatory status for the intended market. Requirements depend on whether the buyer is a contract manufacturer, wholesaler, or hospital pharmacy.
---
Sources
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229464/
[2] https://www.ema.europa.eu/en/glossary/active-substance-api